Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$350K Sell
14,553
-2,130
-13% -$55.7K 0.01% 313
2026
Q1
$468K Sell
16,683
-475
-3% -$12.6K 0.02% 252
2025
Q4
$427K Sell
17,158
-68
-0.4% -$1.72K 0.02% 233
2025
Q3
$439K Sell
17,226
-4,814
-22% -$119K 0.02% 227
2025
Q2
$534K Sell
22,040
-4,818
-18% -$112K 0.02% 198
2025
Q1
$681K Sell
26,858
-1,875
-7% -$49.1K 0.04% 187
2024
Q4
$762K Buy
28,733
+105
+0.4% +$2.85K 0.04% 176
2024
Q3
$829K Sell
28,628
-2,840
-9% -$82.8K 0.05% 162
2024
Q2
$880K Sell
31,468
-14,104
-31% -$388K 0.06% 148
2024
Q1
$1.26M Sell
45,572
-25,963
-36% -$720K 0.09% 121
2023
Q4
$2.06M Sell
71,535
-3,648
-5% -$110K 0.18% 70
2023
Q3
$2.49M Buy
75,183
+1,821
+2% +$64.4K 0.25% 54
2023
Q2
$2.69M Sell
73,362
-5,327
-7% -$207K 0.28% 54
2023
Q1
$3.21M Sell
78,689
-1,552
-2% -$67K 0.37% 43
2022
Q4
$4.11M Buy
80,241
+4,805
+6% +$230K 0.52% 33
2022
Q3
$3.3M Buy
75,436
+3,320
+5% +$161K 0.5% 39
2022
Q2
$3.78M Buy
72,116
+2,428
+3% +$124K 0.61% 32
2022
Q1
$3.61M Buy
69,688
+7,224
+12% +$375K 0.61% 27
2021
Q4
$3.69M Buy
62,464
+19,896
+47% +$986K 0.65% 25
2021
Q3
$1.83M Buy
42,568
+1,222
+3% +$54.1K 0.42% 36
2021
Q2
$1.62M Buy
41,346
+7,863
+23% +$306K 0.4% 35
2021
Q1
$1.24M Buy
33,483
+3,368
+11% +$120K 0.33% 39
2020
Q4
$1.11M Buy
30,115
+7,975
+36% +$293K 0.34% 34
2020
Q3
$771K Buy
22,140
+613
+3% +$21.5K 0.28% 38
2020
Q2
$668K Sell
21,527
-4,600
-18% -$156K 0.26% 41
2020
Q1
$809K Sell
26,127
-888
-3% -$30.3K 0.36% 32
2019
Q4
$1M Sell
27,015
-245
-0.9% -$8.73K 0.38% 34
2019
Q3
$929K Buy
27,260
+1,792
+7% +$65.2K 0.39% 33
2019
Q2
$1.05M Buy
25,468
+4,457
+21% +$177K 0.44% 30
2019
Q1
$847K Buy
21,011
+460
+2% +$18.4K 0.36% 35
2018
Q4
$851K Sell
20,551
-3,780
-16% -$157K 0.41% 32
2018
Q3
$1.02M Sell
24,331
-3,075
-11% -$118K 0.49% 29
2018
Q2
$945K Sell
27,406
-6,181
-18% -$211K 0.48% 28
2018
Q1
$1.12M Sell
33,587
-205
-0.6% -$7.05K 0.58% 25
2017
Q4
$1.17M Buy
33,792
+101
+0.3% +$3.44K 0.57% 26
2017
Q3
$1.16M Buy
33,691
+5
+0% +$161 0.59% 26
2017
Q2
$1.07M Sell
33,686
-106
-0.3% -$3.34K 0.57% 27
2017
Q1
$1.17M Buy
33,792
+1,658
+5% +$52.3K 0.58% 25
2016
Q4
$969K Sell
32,134
-3,485
-10% -$106K 0.53% 30
2016
Q3
$1.15M Buy
35,619
+2,206
+7% +$73.8K 0.63% 25
2016
Q2
$1.12M Sell
33,413
-5,893
-15% -$188K 0.61% 26
2016
Q1
$1.1M Buy
39,306
+3,297
+9% +$94.2K 0.62% 25
2015
Q4
$1.1M Buy
36,009
+93
+0.3% +$2.93K 0.66% 26
2015
Q3
$1.07M Sell
35,916
-1,465
-4% -$47K 0.68% 24
2015
Q2
$1.19M Sell
37,381
-4,626
-11% -$151K 0.76% 22
2015
Q1
$1.39M Buy
42,007
+7,102
+20% +$226K 0.87% 21
2014
Q4
$1.03M Sell
34,905
-524
-1% -$15K 0.67% 24
2014
Q3
$994K Buy
35,429
+1,317
+4% +$37K 0.68% 25
2014
Q2
$961K Buy
34,112
+1,251
+4% +$35.7K 0.65% 26
2014
Q1
$1M Sell
32,861
-492
-1% -$14.7K 0.72% 23
2013
Q4
$969K Sell
33,353
-692
-2% -$20.1K 0.73% 22
2013
Q3
$928K Buy
34,045
+914
+3% +$24.9K 0.75% 23
2013
Q2
$880K Buy
+33,131
New +$915K 0.76% 23

Other funds holding PFE

Zhang Financial's PFE Position: Q2 2026 in Review

Zhang Financial reduced its Pfizer (PFE) stake by 13% in Q2 2026, selling an estimated $55.7K and leaving 14,553 shares worth $350K. The position accounts for 0.01% of the portfolio, ranked #313.

Zhang Financial first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $4.11M in Q4 2022. 1,338 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Zhang Financial held 14,553 shares of Pfizer worth $350K as of Q2 2026.
  • Zhang Financial sold 2,130 Pfizer shares in Q2 2026, an estimated $55.7K.
  • Pfizer made up 0.01% of Zhang Financial's portfolio in Q2 2026, its #313 holding.
  • Zhang Financial first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
  • Zhang Financial's Pfizer position peaked at $4.11M in Q4 2022.
  • 1,338 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Zhang Financial's 13F filing for Q2 2026, filed 30 Jul 2026.